HK1173965A1 - Aqueous patches containing diclofenac-sodium - Google Patents

Aqueous patches containing diclofenac-sodium

Info

Publication number
HK1173965A1
HK1173965A1 HK13101111.7A HK13101111A HK1173965A1 HK 1173965 A1 HK1173965 A1 HK 1173965A1 HK 13101111 A HK13101111 A HK 13101111A HK 1173965 A1 HK1173965 A1 HK 1173965A1
Authority
HK
Hong Kong
Prior art keywords
sodium
patches containing
containing diclofenac
aqueous patches
aqueous
Prior art date
Application number
HK13101111.7A
Other languages
English (en)
Chinese (zh)
Inventor
Takashi Kamakura
Kazuha Tani
Yuichiro Mabuchi
Kazuhito Okada
Original Assignee
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Seiyaku Kk filed Critical Teikoku Seiyaku Kk
Publication of HK1173965A1 publication Critical patent/HK1173965A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK13101111.7A 2009-10-23 2013-01-25 Aqueous patches containing diclofenac-sodium HK1173965A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009244518A JP5421063B2 (ja) 2009-10-23 2009-10-23 ジクロフェナクナトリウム含有水性貼付剤
PCT/JP2010/068311 WO2011049058A1 (ja) 2009-10-23 2010-10-19 ジクロフェナクナトリウム含有水性貼付剤

Publications (1)

Publication Number Publication Date
HK1173965A1 true HK1173965A1 (en) 2013-05-31

Family

ID=43900284

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13101111.7A HK1173965A1 (en) 2009-10-23 2013-01-25 Aqueous patches containing diclofenac-sodium

Country Status (11)

Country Link
US (1) US9168235B2 (xx)
EP (1) EP2491924B8 (xx)
JP (1) JP5421063B2 (xx)
KR (1) KR101727347B1 (xx)
CN (1) CN102596195B (xx)
AU (1) AU2010309050B2 (xx)
CA (1) CA2778009C (xx)
ES (1) ES2457519T3 (xx)
HK (1) HK1173965A1 (xx)
TW (1) TWI468192B (xx)
WO (1) WO2011049058A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
JP6449554B2 (ja) * 2014-03-30 2019-01-09 小林製薬株式会社 外用医薬組成物
JP6580305B2 (ja) * 2014-03-30 2019-09-25 小林製薬株式会社 外用医薬組成物
CN106770747A (zh) * 2016-12-09 2017-05-31 广州迈达康医药科技有限公司 一种他克莫司制剂评价方法
CN108210929A (zh) * 2016-12-21 2018-06-29 北京泰德制药股份有限公司 一种含有依托考昔的药物组合物及其制备方法
JP2020066592A (ja) * 2018-10-24 2020-04-30 帝國製薬株式会社 水性貼付剤
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof
WO2024137819A1 (en) * 2022-12-23 2024-06-27 Annadurai Dharmarajan Topical workout muscle recovery composition and its method of application

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
JPH04217925A (ja) * 1990-03-27 1992-08-07 Nippon Saafuakutanto Kogyo Kk 新規な解熱消炎鎮痛剤組成物
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
JPH06219940A (ja) * 1993-01-27 1994-08-09 Shiseido Co Ltd 貼付剤
JPH0789853A (ja) * 1993-09-24 1995-04-04 Shiseido Co Ltd 貼付剤
JPH11222443A (ja) 1997-11-11 1999-08-17 Saitama Daiichi Seiyaku Kk 経皮吸収促進組成物および経皮吸収製剤
US6698162B2 (en) * 2000-03-23 2004-03-02 Teikoku Pharma Usa, Inc. Methods of producing a terminally sterilized topical patch preparation
KR20020012978A (ko) * 2000-08-10 2002-02-20 이영길 진통소염 효과를 갖는 디클로페낙염을 함유 카타플라스마제
ATE464887T1 (de) 2001-05-31 2010-05-15 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
TW200500100A (en) 2003-02-12 2005-01-01 Teika Pharmaceutical Co Ltd Transdermal patch comprises diclofenac
JP4157018B2 (ja) 2003-11-10 2008-09-24 久光製薬株式会社 消炎鎮痛貼付剤
WO2005102306A1 (ja) * 2004-04-23 2005-11-03 Hisamitsu Pharmaceutical Co., Inc. 消炎鎮痛貼付剤
TWI414320B (zh) * 2004-05-13 2013-11-11 Hisamitsu Pharmaceutical Co 含有非類固醇系消炎鎮痛劑之外用經皮製劑
CA2586871C (en) 2004-11-05 2012-03-13 Lead Chemical Co., Ltd. Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
EP2116234A4 (en) 2006-12-06 2012-01-18 Nipro Patch Co Ltd PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION AND SKIN ADHESIVES

Also Published As

Publication number Publication date
CN102596195A (zh) 2012-07-18
KR20120093239A (ko) 2012-08-22
TW201124177A (en) 2011-07-16
CN102596195B (zh) 2013-10-30
KR101727347B1 (ko) 2017-04-14
TWI468192B (zh) 2015-01-11
EP2491924B8 (en) 2014-06-11
EP2491924B1 (en) 2014-03-26
AU2010309050A1 (en) 2012-05-10
EP2491924A1 (en) 2012-08-29
CA2778009A1 (en) 2011-04-28
EP2491924A4 (en) 2013-04-10
WO2011049058A1 (ja) 2011-04-28
AU2010309050B2 (en) 2014-04-17
JP5421063B2 (ja) 2014-02-19
CA2778009C (en) 2016-08-30
JP2011088862A (ja) 2011-05-06
ES2457519T3 (es) 2014-04-28
US9168235B2 (en) 2015-10-27
US20120207814A1 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
HK1173142A1 (en) N1-sulfonyl-5-fluoropyrimidinone derivatives n1--5-
HK1172893A1 (en) 5-fluoropyrimidinone derivatives 5-
ZA201203205B (en) Benzimidazole-imidazole derivatives
EP2456515A4 (en) NERVE STIMULATION
EP2501753A4 (en) NANOPAPIER RESISTANT
IL216007A0 (en) Isoxazole-pyridine derivatives
ZA201106855B (en) Oxasiazole derivatives
IL215109A0 (en) Isoxazole-pyridazine derivatives
IL214941A0 (en) Isoxazole-pyrazole derivatives
HK1173965A1 (en) Aqueous patches containing diclofenac-sodium
ZA201104991B (en) Deoxyactagardine derivatives
HK1172894A1 (en) N1-acyl-5-fluoropyrimidinone derivatives n1--5-
HK1169623A1 (en) Pyrazinooxazepine derivatives
EP2512482A4 (en) DERIVATIVES OF 2-ALDOXIMINO-5-FLUOROPYRIMIDINE
ZA201104279B (en) Tetrahydronaphthalen-2-ol derivatives
GB0912499D0 (en) Indopyl-pyridone derivatives
GB0916131D0 (en) Fitted sheets-01
AP00242S1 (en) Woodstove
AP2009000321S (en) Doropak